Spot Urine Tests in Predicting 24-Hour Urine Sodium Excretion in Asian Patients

被引:9
作者
Subramanian, Srinivas [1 ]
Teo, Boon Wee [2 ]
Toh, Qi Chun [2 ]
Koh, Yun Yin [2 ]
Li, Jialiang [3 ]
Sethi, Sunil [4 ]
Lee, Evan J. C. [2 ]
机构
[1] Natl Univ Singapore Hosp, Dept Med, Singapore 119228, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore
[3] Natl Univ Singapore, Fac Sci, Dept Stat & Appl Probabil, Singapore 117548, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore
基金
英国医学研究理事会;
关键词
BLOOD-PRESSURE; SALT INTAKE; HYPERTENSION; DISEASE; TRENDS;
D O I
10.1053/j.jrn.2012.12.004
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The control of hypertension is often suboptimal, and it is frequently due to excessive sodium intake. Monitoring sodium intake is cumbersome and involves 24-hour collection of urine. We hypothesize that a spot urine test can accurately predict 24-hour urine sodium excretion in an Asian population. Design: This is a prospective, observational study. We used stored urine specimens (n = 333) from the Asian Kidney Disease Study and Singapore Kidney Function Study Phase I. We measured spot urine tests and correlated these variables to the previously measured 24-hour urine sodium measurements. Results: Age, gender, ethnicity, diastolic blood pressure, height, weight, body mass index, serum creatinine, spot urine sodium, spot urine chloride, and spot urine osmolality were associated with 24-hour urine sodium excretion. The final model for predicting 24-hour urine sodium less than 100 mmol included age, gender, ethnicity, weight, and spot urine sodium. Conclusion: Spot urine sodium can help monitor a patient's sodium intake when used in the derived 5-variable equation. (C) 2013 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:450 / 455
页数:6
相关论文
共 24 条
  • [1] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [2] [Anonymous], 2010, Dietary guidelines for Americans
  • [3] THE MEASUREMENT OF SODIUM AND POTASSIUM INTAKE
    CAGGIULA, AW
    WING, RR
    NOWALK, MP
    MILAS, NC
    LEE, S
    LANGFORD, H
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1985, 42 (03) : 391 - 398
  • [4] Christopher-Stine L, 2004, J RHEUMATOL, V31, P1557
  • [5] A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension
    Dussol, B
    Moussi-Frances, J
    Morange, S
    Somma-Delpero, C
    Mundler, O
    Berland, Y
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (02) : 349 - 353
  • [6] US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
    Egan, Brent M.
    Zhao, Yumin
    Axon, R. Neal
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (20): : 2043 - 2050
  • [7] Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge
    He, J
    Whelton, PK
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) : 327 - 331
  • [8] Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, 7 NIH JOINT NAT COMM
  • [9] Kidney Disease Outcomes Quality Initiative (K/DOQI), 2004, Am J Kidney Dis, V43, pS1
  • [10] EFFECT OF DIURETIC DRUGS ON CREATININE CLEARANCE DETERMINATION
    LAM, NP
    KUK, JM
    FRANSON, KL
    LAU, AH
    [J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (02) : 142 - 144